Cargando…

COVID-19 Diagnosis: Current and Future Techniques

COVID-19 pandemic continues to be a global threat, affecting more than 200 countries/territories at both human and economic level. This necessitates the rapid development of highly reliable diagnostic methods in order to effectively and accurately diagnose the pathology to prevent the spread of COVI...

Descripción completa

Detalles Bibliográficos
Autores principales: Sharma, Aarjoo, Balda, Sanjeev, Apreja, Mansi, Kataria, Kirti, Capalash, Neena, Sharma, Prince
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier B.V. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8585557/
https://www.ncbi.nlm.nih.gov/pubmed/34774862
http://dx.doi.org/10.1016/j.ijbiomac.2021.11.016
_version_ 1784597716068728832
author Sharma, Aarjoo
Balda, Sanjeev
Apreja, Mansi
Kataria, Kirti
Capalash, Neena
Sharma, Prince
author_facet Sharma, Aarjoo
Balda, Sanjeev
Apreja, Mansi
Kataria, Kirti
Capalash, Neena
Sharma, Prince
author_sort Sharma, Aarjoo
collection PubMed
description COVID-19 pandemic continues to be a global threat, affecting more than 200 countries/territories at both human and economic level. This necessitates the rapid development of highly reliable diagnostic methods in order to effectively and accurately diagnose the pathology to prevent the spread of COVID-19. Currently, RT-PCR is the most widely used method worldwide for SARS-CoV-2 detection. Serological assays are being used for sero-surveys of SARS-CoV-2 antibody prevalence in the community. Radiology imaging has been useful in the clinical diagnosis of COVID-19. These methods have their own limitations and there are continued efforts to develop easier, economic, highly sensitive and specific, point-of-care methods. Reverse transcription-loop mediated isothermal amplification (RT-LAMP), nucleic acid sequence-based amplification (NASBA), CRISPR-Cas-based detection, and digital PCR are such techniques being employed in research laboratories, with many awaiting diagnostic approval from competent authorities. This review highlights the rapidly expanding array of existing and in-development diagnostic tests/strategies that may be used to diagnose SARS-CoV-2 infection in both clinical and research settings.
format Online
Article
Text
id pubmed-8585557
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Published by Elsevier B.V.
record_format MEDLINE/PubMed
spelling pubmed-85855572021-11-12 COVID-19 Diagnosis: Current and Future Techniques Sharma, Aarjoo Balda, Sanjeev Apreja, Mansi Kataria, Kirti Capalash, Neena Sharma, Prince Int J Biol Macromol Review COVID-19 pandemic continues to be a global threat, affecting more than 200 countries/territories at both human and economic level. This necessitates the rapid development of highly reliable diagnostic methods in order to effectively and accurately diagnose the pathology to prevent the spread of COVID-19. Currently, RT-PCR is the most widely used method worldwide for SARS-CoV-2 detection. Serological assays are being used for sero-surveys of SARS-CoV-2 antibody prevalence in the community. Radiology imaging has been useful in the clinical diagnosis of COVID-19. These methods have their own limitations and there are continued efforts to develop easier, economic, highly sensitive and specific, point-of-care methods. Reverse transcription-loop mediated isothermal amplification (RT-LAMP), nucleic acid sequence-based amplification (NASBA), CRISPR-Cas-based detection, and digital PCR are such techniques being employed in research laboratories, with many awaiting diagnostic approval from competent authorities. This review highlights the rapidly expanding array of existing and in-development diagnostic tests/strategies that may be used to diagnose SARS-CoV-2 infection in both clinical and research settings. Published by Elsevier B.V. 2021-12-15 2021-11-12 /pmc/articles/PMC8585557/ /pubmed/34774862 http://dx.doi.org/10.1016/j.ijbiomac.2021.11.016 Text en © 2021 Published by Elsevier B.V. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Review
Sharma, Aarjoo
Balda, Sanjeev
Apreja, Mansi
Kataria, Kirti
Capalash, Neena
Sharma, Prince
COVID-19 Diagnosis: Current and Future Techniques
title COVID-19 Diagnosis: Current and Future Techniques
title_full COVID-19 Diagnosis: Current and Future Techniques
title_fullStr COVID-19 Diagnosis: Current and Future Techniques
title_full_unstemmed COVID-19 Diagnosis: Current and Future Techniques
title_short COVID-19 Diagnosis: Current and Future Techniques
title_sort covid-19 diagnosis: current and future techniques
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8585557/
https://www.ncbi.nlm.nih.gov/pubmed/34774862
http://dx.doi.org/10.1016/j.ijbiomac.2021.11.016
work_keys_str_mv AT sharmaaarjoo covid19diagnosiscurrentandfuturetechniques
AT baldasanjeev covid19diagnosiscurrentandfuturetechniques
AT aprejamansi covid19diagnosiscurrentandfuturetechniques
AT katariakirti covid19diagnosiscurrentandfuturetechniques
AT capalashneena covid19diagnosiscurrentandfuturetechniques
AT sharmaprince covid19diagnosiscurrentandfuturetechniques